BBN-RGD peptide heterodimers (Acaduceus)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameBBN-RGD peptide heterodimers (Acaduceus)

Drug Alias Name90Y-labeled BBN-RGD peptide heterodimers (Acaduceus)bombesin-Arg-Gly-Asp peptide heterodimers (Acaduceus)177Lu-labeled BBN-RGD peptide heterodimers (Acaduceus)

ClassificationRadiation-emitting productsBiologics > Protein drugs > Recombinant polypeptide

Mechanisms of ActionIntegrin modulatorsGastrin-releasing peptide modulators

TargetsIntegrinGastrin-releasing peptide

Therapy Area/IndicationsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAcaduceus Pharmaceutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAcaduceus Pharmaceutics Inc

Active IndicationsN/A

Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A